 Use neuroleptic-induced extrapyramidal symptoms future vulnerability effects OBJECTIVE Susceptibility neuroleptic-induced extrapyramidal syndromes varies age sex subgroups Individual vulnerability syndromes utility past history future occurrence extrapyramidal syndromes investigation patients previous histories extrapyramidal syndromes future episodes extrapyramidal syndromes importance predictive factor patient age sex neuroleptic dose predictors extrapyramidal syndromes METHODS charts schizophrenic patients multiple neuroleptic treatment episodes Extrapyramidal neuroleptic drug doses anticholinergic drug doses first days treatment episode RESULTS Previous extrapyramidal syndromes extrapyramidal syndromes subsequent treatments patients Variations neuroleptic potency neuroleptic dose incorrect predictions CONCLUSIONS results hypothesis patients history extrapyramidal syndromes risk future extrapyramidal syndromes results individual susceptibility major predictor extrapyramidal syndromes prophylaxis extrapyramidal syndromes patients extrapyramidal syndromes neuroleptic therapy